← Back to Clinical Trials
Recruiting NCT06568107

NCT06568107 Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06568107
Status Recruiting
Phase —
Sponsor Drexel University
Condition Dementia
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2024-10-31
Primary Completion 2025-07

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Environmental And Sensory Experience (EASE) intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2024-10-31 with a primary completion date of 2025-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to test a person-centered, nature-based non-pharmacological intervention for nursing home residents living with dementia who exhibit persistent vocalizations. The Environmental And Sensory Experience (EASE) involves the projection of a still nature image and the playing of nature sounds. Family members of the person living with dementia provide consent for the resident to participate in the study and complete a brief survey on nature preferences on the resident's behalf. The survey informs the research team on what nature scene to show. Participants will wear a watch that measures stress levels and research staff will monitor vocalization patterns. We will also recruit persons living with dementia from other settings such as assisted living, personal care units, and adult day care settings.

Eligibility Criteria

Inclusion Criteria: * The participants must: 1) have a medical diagnosis of dementia; 2) have severe dementia as determined by a MMSE score of ≤9 (or another cognitive test indicating severe dementia); 3) have a history of PVs per staff report; 4) be 50 years older or greater; 5) require extensive assistance by staff to ambulate or is non-ambulatory (to allow for consistent video recording). In addition, consent will be obtained from the resident's Legally Authorized Representative (LAR) and assent from the participant. Exclusion Criteria: * Persons living with dementia will be excluded if they: 1) are blind; 2) are deaf; 3) give indications of dissent. Variations will be sought for gender, race and ethnicity.

Contact & Investigator

Central Contact

Justine S Sefcik, PhD, RN

✉ jss398@drexel.edu

📞 6074347205

Principal Investigator

Justine S Sefcik

PRINCIPAL INVESTIGATOR

Drexel University

Frequently Asked Questions

Who can join the NCT06568107 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06568107 currently recruiting?

Yes, NCT06568107 is actively recruiting participants. Contact the research team at jss398@drexel.edu for enrollment information.

Where is the NCT06568107 trial being conducted?

This trial is being conducted at Philadelphia, United States.

Who is sponsoring the NCT06568107 clinical trial?

NCT06568107 is sponsored by Drexel University. The principal investigator is Justine S Sefcik at Drexel University. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology